Weiler, M <br/><br/>
Suppression of proinvasive RGS4 by mTOR inhibition optimizes glioma treatment.  [electronic resource] 

 -  Oncogene  Feb 2013 
 - 1099-109 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5594 
<br/><br/><label>Standard No.: </label>10.1038/onc.2012.137  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Animals<br/>Astrocytoma--drug therapy<br/>Cell Line, Tumor<br/>Cell Movement--drug effects<br/>Female<br/>Glioblastoma--drug therapy<br/>Humans<br/>Male<br/>Mice<br/>Mice, Inbred Strains<br/>Middle Aged<br/>Neoplasm Invasiveness--prevention & control<br/>Protein Kinase Inhibitors--therapeutic use<br/>RGS Proteins--metabolism<br/>Sirolimus--analogs & derivatives<br/>TOR Serine-Threonine Kinases--antagonists & inhibitors